Cleared Traditional

K150817 - Dario Blood Glucose Monitoring System

K150817 is an FDA 510(k) clearance for Dario Blood Glucose Monitoring System, manufactured by Labstyle Innovations, Ltd.. The device is a Class 2 Chemistry device with product code NBW cleared through the Traditional 510(k) pathway after a 269-day FDA review.

K150817 · Labstyle Innovations, Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2015
Decision
269d
Days
Class 2
Risk

K150817 is an FDA 510(k) clearance for the Dario Blood Glucose Monitoring System. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Labstyle Innovations, Ltd. (Charlott, US). The FDA issued a Cleared decision on December 21, 2015 after a review of 269 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Labstyle Innovations, Ltd. devices

FDA 510(k) Submission Details - K150817

510(k) Number K150817 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 27, 2015
Decision Date December 21, 2015
Days to Decision 269 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
181d slower than avg
Panel avg: 88d · This submission: 269d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 420
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K150817.
TRUE METRIX GO Self Monitoring Blood Glucose System
K143548 · Trividia Health, Inc. · Apr 2016
FreeStyle Precision Neo H Blood Glucose Monitoring System
K153330 · Abbott Diabetes Care, Inc. · Feb 2016
MyGlucoHealth Wireless System
K143169 · Entra Health Systems · Jan 2016
PRODIGY iConnect Blood Glucose Monitoring System
K142785 · Ok Biotech Co., Ltd. · Dec 2015
Freestyle Freedom Blood Glucose Monitoring Sytem
K152442 · Abbott Laboratories · Dec 2015
OneTouch Ultra Plus Flex Blood Glucose Monitoring System
K151611 · Lifescan Europe · Dec 2015